More News

09 Feb 2007 GlaxoSmithKline and Fabre-Kramer Pharmaceuticals enter global agreement for new treatment of major depressive disorder
09 Feb 2007 SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate
09 Feb 2007 BioSyntech announces start of patient recruitment into BST-DermOn(TM) pivotal clinical trial
09 Feb 2007 BioSyntech announces start of patient recruitment into BST-DermOn(TM) pivotal clinical trial
08 Feb 2007 Ranbaxy Announces Global Entry Into Biosimilars With Zenotech
08 Feb 2007 Lupin Pharmaceuticals, Inc. Receives US FDA Approval For Sertraline
07 Feb 2007 ImClone Systems Opts-out of Development Agreement with UCB to Focus Resources on Proprietary, Anti-VEGFr-2 Antibody IMC-1121B
07 Feb 2007 Ranbaxy Signs A New R&D Agreement With Gsk
07 Feb 2007 Mylan Announces Final FDA Approval for Sertraline Hydrochloride Tablets
07 Feb 2007 KineMed and Bayer Healthcare AG Enter Collaboration to Discover New Therapeutic Applications for Drug Candidates
07 Feb 2007 Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
06 Feb 2007 AstraZeneca Licenses Regeneron's Velocimmune(R) Technology For Discovering Human Monoclonal Antibodies
06 Feb 2007 Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
06 Feb 2007 Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
06 Feb 2007 Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
06 Feb 2007 Roche continues to strengthen Research and Development
06 Feb 2007 Antisense Therapeutics Extends its Drug Discovery and Development Collaboration with Isis Pharmaceuticals
06 Feb 2007 elbion and Wyeth Enter Collaboration to Develop New Treatments for Schizophrenia
06 Feb 2007 UCB Licenses BioWa's POTELLIGENT(R) Technology for use in Antibody Research and Development
05 Feb 2007 Diabetes Prevalence
03 Feb 2007 Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation Enter into A Basic Agreement to Merge on October 1, 2007
03 Feb 2007 Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
03 Feb 2007 Biodelivery Sciences Announces FDA Acceptance of Bioral Amphotericin IND
02 Feb 2007 Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline
02 Feb 2007 AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top